切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2023, Vol. 09 ›› Issue (02) : 120 -125. doi: 10.3877/cma.j.issn.2095-9605.2023.02.008

论著

单吻合口胃旁路术对于肥胖及糖尿病患者心脑血管风险的影响
秦晓光, 毛忠琦, 周晓庆, 谢尔凡, 吴国强, 张敏, 李威杰()   
  1. 215010 苏州,南京医科大学附属明基医院苏州院区代谢与减重医学中心;215000 苏州,苏州大学附属第一医院胃肠外科
    215010 苏州,南京医科大学附属明基医院苏州院区代谢与减重医学中心
  • 收稿日期:2021-10-28 出版日期:2023-05-30
  • 通信作者: 李威杰

Effects of OAGB surgery on cardiovascular and cerebrovascular risk in patients with obesity and diabetes mellitus

Xiaoguang Qin, Zhongqi Mao, Xiaoqing Zhou, Erfan Xie, Guoqiang Wu, Min Zhang, Weijie Lee()   

  1. Department of Bariatric/Metabolic Surgical Center, Suzhou BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Suzhou 215010, China; Department of Gastrointestinal Surgery, the First Affiliated Hospital of Soochow University, Suzhou 215000, China
    Department of Bariatric/Metabolic Surgical Center, Suzhou BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Suzhou 215010, China
  • Received:2021-10-28 Published:2023-05-30
  • Corresponding author: Weijie Lee
引用本文:

秦晓光, 毛忠琦, 周晓庆, 谢尔凡, 吴国强, 张敏, 李威杰. 单吻合口胃旁路术对于肥胖及糖尿病患者心脑血管风险的影响[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 120-125.

Xiaoguang Qin, Zhongqi Mao, Xiaoqing Zhou, Erfan Xie, Guoqiang Wu, Min Zhang, Weijie Lee. Effects of OAGB surgery on cardiovascular and cerebrovascular risk in patients with obesity and diabetes mellitus[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(02): 120-125.

目的

探讨分析肥胖及糖尿病患者单吻合口胃旁路术(OAGB)手术前后英国糖尿病心血管疾病风险因子(UKPDS)的变化,从而客观评估患者术后远期冠心病及脑卒中发生风险的获益。

方法

回顾性分析2019年9月至2020年6月在苏州明基医院代谢与减重医学中心接受减重手术的30名肥胖及糖尿病患者的临床资料,其中2型糖尿病(T2DM)组及单纯性肥胖组各15例,使用UKPDS评估手术前后心血管风险因子改变,所有手术病人年龄在18~60岁,均为肥胖症患者(BMI>32.5 kg/m2),手术方式为腹腔镜OAGB,其中术后患者的数据为术后6个月随访数据,使用SPSS 25进行数据统计。

结果

术后6个月,两组患者冠心病(CHD)及脑卒中(stroke)的风险均有下降(P<0.05),手术后对于患者CHD、致命性冠心病(Fatal CHD)、Stroke以及致命性脑卒中(Fatal Stroke)的发生率有一定改善(两组患者术后P<0.05)。其中单纯性肥胖组手术前后Fatal CHD(0.8±1.2 vs. 0.4±0.9,P=0.008)及Fatal Stroke(0.1±0.2 vs. 0.05±0.13,P=0.027)下降明显,而糖尿病组中手术前后CHD(8.28±5.28 vs. 4.07±2.86,P<0.001)和致命性CHD (3.5±2.79 vs. 1.28±1.18,P=0.001)下降更明显。

结论

OAGB可有效降低肥胖及糖尿病患者术后远期心脑血管疾病的发病风险,其中肥胖伴T2DM的患者获益更多,因此对于肥胖伴T2DM的患者更推荐早期行OAGB手术治疗。

Objective

In order to objectively evaluate the benefits of long-term coronary heart disease (CHD) and stroke in obese and diabetic patients, the changes of UK diabetes cardiovascular disease risk factors (UKPDS) before and after One-anastomosis gastric bypass were investigated.

Methods

Data of this study are obtained from the bariatric/metabolic surgical center of Suzhou Benq Hospital. A total of 30 patients with obesity and diabetes, including 15 patients in type 2 diabetic mellitus (T2DM) group and 15 patients in obesity group, were enrolled from September 2019 to june 2020. UKPDS was used to assess changes in cardiovascular risk factors before and after surgery. All patients aged 18 to 60 years were obese (BMI>32.5 kg/m2), and metabolic surgery was performed by laparoscopic one single anastomotic gastric bypass (OAGB). SPSS 25 was used for statistical analysis.

Results

6 months after surgery, the risks of coronary heart disease (CHD) and Stroke were decreased in both groups (P<0.05). There was some improvement in the incidence of CHD, Fatal CHD, Stroke, and Fatal Stroke after surgery (P<0.05 in both groups). Fatal CHD and Fatal Stroke decreased significantly in the obesity group (0.8±1.2 vs. 0.4±0.9; P=0.008 and 0.1±0.2 vs. 0.05±0.13, P=0.027), while CHD and Fatal CHD decreased more significantly in the diabetic group(8.28±5.28 vs. 4.07±2.86, P<0.001 and 3.5±2.79 vs. 1.28±1.18, P=0.001),

Conclusions

Metabolic surgery can effectively reduce the risk of long-term cardiovascular and cerebrovascular diseases in obese and diabetic patients, and obese patients with T2DM have more benefits, so early metabolic surgery is recommended for obese patients with T2DM.

表1 手术前后患者基线信息
表2 糖尿病组及单纯肥胖病组手术前后数据
表3 两组患者手术前后UKPDS情况
[1]
Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 [J]. Lancet, 2021, 397(10292): 2385-2438.
[2]
Scopinaro N. The IFSO and obesity surgery throughout the world [J]. Obesity Surgery, 1998, 8(1): 3-8.
[3]
Buchwald H, Oien DM. Metabolic / Bariatric surgery worldwide 2008 [J]. Obesity Surgery, 2009, 19(12): 1605-1611.
[4]
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013 [J]. Obesity Surgery, 2015, 25(10):1822-1832.
[5]
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014 [J]. Obesity Surgery, 2017, 27(9): 1-11.
[6]
Maurizio DL, Tiffany T, Geraldine O, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSOposition statement [J]. Obesity Surgery, 2018, 28(5): 1188-1206.
[7]
中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖及2型糖尿病外科治疗指南(2019版) [J]. 中国实用外科杂志, 2019, 39(4): 301-306.
[8]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会,中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库:2021年度报告 [J/CD]. 中华肥胖与代谢病电子杂志, 2022, 8(1): 15-23.
[9]
Han Zhe, Wang Yang, Li Jing. Effects of Atorvastatin Combined with Nano-Selenium on Blood Lipids and Oxidative Stress in Atherosclerotic Rats [J]. J Nanosci Nanotechnol, 2021, 21(2): 1331-1337.
[10]
Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect [J]. Obes Surg, 2014, 24(9): 1552-62.
[11]
Wu WC, Lee WJ, Lee TH, et al. Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and-9 among patients with type 2 diabetes mellitus? [J]. World J Diabetes, 2020, 11(6): 252-260.
[12]
Khoraki J, Campos GM. Comment on:Predictors of diabetes relapse after metabolic surgery in Asia [J]. Surgery for Obesity and Related Diseases, 2022, 18(4): 461-463.
[13]
Aminian A, Wilson R, Zajichek A, et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care [J]. Diabetes Care, 2021, 44(11): 2552-2563.
[14]
Buchwald H,Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [J]. Acc Current Journal Review, 2004, 14(14): 13-13.
[15]
Jones AR, Tovee MJ, Cutler LR, et al. Health effects of overweight and obesity in 195 Countries over 25 Years [J]. Yearbook of Paediatric Endocrinology, 2018, 377(1): 13-27.
[16]
Pournaras DJ, Welbourn R. Weight loss surgery and cardiovascular risk and mortality in patients with type 2 diabetes [J]. Lancet Diabetes Endocrinol, 2015, 3(11): 828-829.
[17]
Sjostrom L. Long-Term Mortality after Gastric Bypass Surgery—NEJM. 2007. 4 - 6. Print.
[18]
Benraouane F, Litwin SE. Reductions in cardiovascular risk after bariatric surgery [J]. Current Opinion in Cardiology, 2011, 26(6): 555.
[19]
Lars S, Markku P, Peter J, et al. Bariatric Surgery and Long-term Cardiovascular Events [J]. Jama, 2012, 307(1): 56-65.
[20]
Eliasson B, Liakopoulos V, Franzén S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study [J]. Lancet Diabetes Endocrinol, 2015, 3(11): 847-854.
[21]
Lakdawala M, Shaikh S, Bandukwala S, et al. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m2) Indian patients with type 2 diabetes mellitus [J]. Surgery for Obesity & Related Diseases, 2013, 9(3): 370-378.
[22]
Hsu CC, Almulaifi A, Chen JC, et al. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes [J]. Jama Surgery, 2015, 150(12): 1.
[23]
LGenser, CB. Bariatric surgery versus intensive medical therapy for diabetes -5- year outcomes [J]. Obésité, 2017, 376(7): 641-651.
[24]
Ikramuddin S, Korner J, Wei JL, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study [J]. JAMA, 2018, 319(3): 266.
[25]
Cohen RV, Pinheiro JC, Schiavon CA , et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity [J]. Diabetes care, 2012, 35(7): 1420-1428.
[26]
Aung L, Lee WJ, Chen SC, et al. Bariatric surgery for patients with early-onset vs late-onset type 2 diabetes [J]. Jama Surg, 2016, 151(9): 798-805.
[27]
Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study [J]. Lancet Diabetes & Endocrinology, 2017, 5(3): 174-183.
[28]
Angrisani L, Santonicola A,Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014 [J]. Obesity Surgery, 2017, 27(9): 1-11.
[29]
Wei JH, Chou RH, Huang PH, et al. Metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: Influence of different surgical procedures [J]. Surgery for Obesity and Related Diseases, 2018, 14(12): 1832-1840.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[3] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[4] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[6] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[7] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[8] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[9] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[10] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
[11] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[12] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[13] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[14] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[15] 向林, 江云颂, 程吕佳, 关炳生, 杨景哥. 生长素释放肽在肥胖治疗中的潜在应用价值研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 235-241.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?